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Background: Tobacco use is a public health problem, responsible for approximately six million deaths annually
worldwide. It is a risk factor for many diseases including cancers, respiratory and cardiovascular diseases. In low-and
middle-income countries, respiratory and cardiovascular diseases are important causes of death. Tobacco use is
prevalent in Ghana, but no study had examined the relationship between tobacco use and deaths from respiratory
and cardiovascular diseases in the Upper East Region of Northern Ghana. Hence the paper assessed the association
between tobacco use and deaths from respiratory and cardiovascular diseases in that region.
Methods: The study used verbal autopsy data collected from the Kassena-Nankana East and West districts of the
Upper East Region of Northern Ghana. Data from deceased individuals aged 15 to 59 years whose deaths occurred
between January 1, 2004 and December 31, 2011 and with a known cause as well as smoking status were analyzed.
Two binary outcome variables were generated from the cause of death data; whether an individual died from
respiratory diseases or not, and from cardiovascular diseases or not. Multiple logistic regression models were used
to assess the relationship between tobacco use and deaths from respiratory and cardiovascular diseases.
Results: Out of 3,492 deaths with a known cause of death and smoking status, a third of them smoked. About
16.6% of smokers and 8.1% of non-smokers died from respiratory diseases. Approximately, 10.7% of smokers died
from cardiovascular diseases compared to 10.6% of non-smokers. In multivariate analyses, individuals with a history
of smoking had two-fold increased odds [OR=2.18, 95% CI (1.6-2.9)] of dying from respiratory diseases. Besides, the
number of years of smoking as well as the frequency of smoking is significantly associated with deaths from
respiratory diseases. No association existed between tobacco use and deaths from cardiovascular diseases.
Conclusions: Within our study we identified a strong relationship between tobacco use and deaths from
respiratory diseases, but not an association with deaths from cardiovascular diseases. Our findings highlight the
need to make appropriate health interventions to control tobacco use and thus help reduce premature deaths
from respiratory and other tobacco linked diseases.
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Tobacco use is increasingly a public health problem.
Globally, an estimated 6 million people died in 2011 due
to smoking [1,2]. It is further projected to kill 50% more
people by 2015 than the disease HIV/AIDS [3] and these
estimates are expected to rise to 8 million by 2030 if the
trend is left unchecked [1]. The burden of tobacco use is
gradually shifting from high to low- and middle-income
countries [4,5], since the multi-national companies
involved in the tobacco industry intend making up for the
losses in the advanced countries [2,6,7]. Following this,
deaths attributed to tobacco use are expected to reduce by
9% between 2002 and 2030 in the developed countries,
but estimated to double from 3.4 million to 6.8 million
annually in low- and middle-income countries [3].
Tobacco use is one of the major risk factors for non-
communicable diseases [3,8-11] some of which include
cardiovascular and respiratory diseases, cancers, etc.
Globally, cancer, cardiovascular and chronic respiratory
diseases are gauged to be the leading causes of deaths by
2015 [3].
In the context of low-and middle-income countries,
cardiovascular diseases are important causes of deaths [12].
According to the WHO, over 80% of the global deaths from
cardiovascular diseases occur in low- and middle-income
countries, disproportionally affecting the poorest in these
settings [13]. A verbal autopsy approach in Vietnam
demonstrated that cardiovascular diseases were the lead-
ing cause of death in 1999 [14]. Respiratory diseases are
also noted to have caused a devastating effect in Africa
[15]. Indeed, tobacco users in Africa are expected to die
20 to 25 years earlier from various cancers, respiratory
diseases, as well as cardiovascular diseases [16].
Tobacco use is prevalent in Ghana. The common forms
of usage include not only cigarette smoking, but also pipe
smoking, chewing, sniffing and oral or nasal use [17]. Until
recently, there were no studies showing tobacco preva-
lence for the whole country Ghana [18], most prevalence
studies were conducted in the southern urban areas. How-
ever, a recent study using data from the 2008 Ghana
Demographic and Health Survey found the prevalence of
cigarette smoking and other tobacco products to be 7.9%
for men and 0.4% for women [18]. As it is in other coun-
tries, the evidence demonstrated that tobacco use in
Ghana is high among men, rural residents, the poor and
those with no formal education [7,18,19].
Geographically, the three regions of Northern Ghana
which are considered the poorest, lead in the prevalence
rates for cigarette and other tobacco products usage;
31.2% for Upper East Region, 22.5% for Northern Region,
and 7.9% for Upper West Region [19]. Despite this high
prevalence, no study has documented the relationship
between tobacco use and deaths from respiratory and
cardiovascular diseases in Northern Ghana, especiallythe Upper East Region which had the highest prevalence
rate. This paper used verbal autopsy data to explore the
relationship between tobacco use and deaths from respira-
tory and cardiovascular diseases among adults aged 15 to
59 years in the Kassena-Nankana East and West districts
of the Upper East Region of Northern Ghana.
Verbal autopsy data is used against the background
that certification of deaths in Africa is uncommon. Ac-
cording to Adjuik et al., the registration of deaths in Africa
is less than 10% compared to the situation in Europe
which is almost 100% [20]. Besides, access to health care
services is limited and most deaths take place outside
health facilities, and thus very challenging to ascertain the
cause of death for each individual. But certification of
deaths assist to understand the key causes of death in
order to take appropriate policy action or implement in-
terventions directed to specific causes. Verbal autopsy is
an innovative way of understanding the causes of deaths
in the absence of official certification. It is an interview
tool that is used in various places and settings to collect
data on causes of death [21], especially in settings with
poor vital statistics and weak health systems. This paper
contributes to our understanding of the relationship be-
tween smoking and dying from respiratory and cardiovas-
cular diseases in the study area and other similar settings.
This is essential for the development of effective and effi-
cient health policies on tobacco use and the evaluation of
existing programs and policies. It will also provide justifi-
cation for spending on policies on tobacco use by the
Government of Ghana.
Methods
Study design and setting
The study was cross sectional and carried out in the
Kassena-Nankana East and West districts (previously
the Kassena-Nankana districts) of the Upper East Region
of Northern Ghana. There are approximately 153, 293
residents in the two districts [22]. The districts have a
total land area of 1,674 square kilometers and mainly
covered by the Sahel and Sudan-Savannah types of vege-
tation. Topographically, the land area is low-lying with
an average height of 1,000 meters above sea level. Aver-
age rainfall per annum is 950 mm. In all, there are 216
communities in the districts, of which majority are rural,
with only 13% of the population living in urban areas.
The main economic activity for the people is agricul-
ture (70%). The districtsare considered among the
poorest in Ghana, due to their reliance on subsistence
agriculture.
Existing health facilities include 6 health centres, a dis-
trict hospital, 27 community-based health and planning
services (CHPS) compounds, 2 faith-based health facil-
ities and 3 private clinics. In 2007, the doctor-patient ra-
tio was 1:31927 [23]. Malaria, respiratory infections, skin
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death for the year 2008 [23].
Data
The study used verbal autopsy data to determine the
association between tobacco use and deaths from respira-
tory and cardiovascular diseases. The verbal autopsy data
was collected by the Navrongo Health Research Centre
through the Health and Demographic Surveillance System
(HDSS). The HDSS is a community registration system
that collects and updates longitudinal data on births,
deaths, pregnancies, marriages and migrations every four
months. The HDSS also conducts verbal autopsy for all
deaths registered in the surveillance system [22,24]. In
2003, the verbal autopsy tool was modified to collect add-
itional information on the lifestyle of all deceased individ-
uals including their drinking and smoking patterns. The
verbal autopsy instrument has both open-and close-ended
questions that document information on the signs, symp-
toms, lifestyle (smoking and drinking patterns) and cir-
cumstances leading to death [25,26]. The tool includes a
section for verbatim narrations of the circumstances lead-
ing to death. The data is usually collected through inter-
views with close relatives of the deceased using the verbal
autopsy instrument. To minimize recall bias by respon-
dents, the interviews are conducted on average 3 months
after a death has occurred. Experienced field supervisors
are used to carry out the interviews.
Upon completion of the verbal autopsy questionnaire
forms, the next stage involved the assignment of possible
cause of death by physicians. Three physicians independ-
ently review each verbal autopsy questionnaire form and
assign an underlying cause of death corresponding to
the 3-digit code of the international statistical classifica-
tion of diseases and health-related problems [27]. If at
least two agree on the underlying cause of death, a diagno-
sis was established. Where there was disagreement among
all three, the form was submitted to two additional physi-
cians for review. Where there was verbal autopsy informa-
tion but no underlying cause of death could be agreed
on, the case was declared undetermined. Where little
or no information was available to enable an assignment
of cause of death, the diagnosis was declared unknown/
undetermined.
Measurement of smoking among the deceased
In measuring the smoking status of the deceased, ques-
tions are asked a close relative who provided care for the
deceased prior to death, whether the deceased ever used
or smoked tobacco during his/her life time. If the re-
sponse is “yes”, then further questions are asked on the
duration of smoking/use of tobacco, frequency, quantity
of cigarette smoked/tobacco used, and type of cigarette/
tobacco consumed.Variables
The main exposure variable for the analysis was the
smoking status of the deceased prior to death. On the
other hand, the outcome variables for the study were
respiratory and cardiovascular diseases. First we deter-
mined whether an individual died from respiratory
disease or not. If an individual died from respiratory dis-
ease, it was categorized as 1, and 0 if otherwise. For this
analysis, we classified the following diseases under the
category of respiratory diseases; chronic obstructive lung
disease, tuberculosis, asthma, acute respiratory infections
(including pneumonia and influenza), and other respira-
tory system illness (including empyema, fistula etc.). The
second outcome variable was whether an individual died
from cardiovascular disease or not, (1, if the death was
associated with cardiovascular disease, and 0 if other-
wise). The following diseases were also classified as car-
diovascular diseases; hypertensive heart disease, ischemic
heart disease, cerebrovascular disease and all other car-
diovascular diseases. Other diseases not related to either
respiratory or cardiovascular diseases were categorized
as “other”.
Data analysis
The analysis was done using STATA 11.2 [28]. All deaths
aged 15–59 years and occurring between January 1, 2004
and December 31, 2011 were analyzed. Individuals were
more likely to initiate smoking at age 15 and thus the
reason for using the age group 15 years and above. Be-
sides, the age range 15–59 years was considered the
productive age group. Therefore deaths occurring be-
tween that age group imply a greater loss of life expect-
ancy, having a substantial impact on society. Overall
4,294 adult deaths occurred in the specified period.
Figure 1 shows the distribution of deaths for the period.
Separate multiple logistic regression models were utilized
to assess the relationship between tobacco use and dying
from respiratory diseases, and again between tobacco use
and dying from cardiovascular diseases. Adjusted odds ratios
(OR) with 95% confidence intervals (CIs) were calculated.
Reference categories were defined as those usually associated
with the lowest risk of dying from respiratory or cardiovascular
diseases. Potential confounding variables controlled for
were age, sex, place of residence and socio-economic status
using wealth index generated from household assets using
principal component analysis (PCA). The potential
confounding variables were arrived at based on their
association with tobacco use and dying from respiratory
or cardiovascular diseases from previous studies. Besides,
socio-economic status was classified as poorest, poorer,
poor, less poor, and least poor. Assets used for the
socio-economic computation included both large (for
example, land and car ownership) and small household
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Figure 1 Distribution of deaths for the period 2004–2011.
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Verbal consent was obtained from household heads or
any other senior member of the household before carrying
out each update for the health and demographic surveil-
lance system. The update for household members was
done every four months which includes the collection of
the verbal autopsy data. This consent process had been
approved by the Institutional Review Board (IRB) of the
Navrongo Health Research Centre.Results
Background characteristics of deaths from respiratory and
cardiovascular diseases
Table 1 describes the percentage distribution of the back-
ground characteristics of the deaths. Among the deaths
with a known smoking status (3,492), approximately 31.7%
(1,106) of them were reported to be tobacco smokers
preceding their death. About 16.6% of tobacco smokers
and 8.1% of non-smokers died from respiratory diseases.
Among the smokers, 10.7% died from cardiovascular dis-
eases compared to 10.6% of non-smokers. About 50.8% of
men and 2.2% of women were tobacco smokers. Around
12.3% of men and 8.5% of women died from respiratory
diseases. There was no marked difference in cardiovascu-
lar deaths by sex with 10.4% of men and 11.1% of womendying from cardiovascular diseases. The median age of the
deceased was 45 years (IQR: 35–53).
Association between tobacco use and deaths from
respiratory diseases
Table 2 shows the relationship between smoking and
dying from respiratory diseases. Individuals who smoked
were associated with more than two-fold increased odds
of dying from respiratory diseases, in bivariate [OR = 2.31,
95% CI (1.9-2.9)] and multivariate analysis [OR = 2.18,
95% CI (1.6-2.9)]. Likewise, the bivariate analysis indicated
that, being older than 30 years, male sex, living in a rural
area and a lower socio-economic status was associated
with increased odds of dying from respiratory diseases.
However, after adjustment for other confounding variables, it
was only age that remained significant. Individuals in the age
group 50–59 had nearly two-fold increased odds [OR = 1.99,
95% CI (1.3-3.0)] of dying from respiratory diseases. There
was no significant association between educational achieve-
ment and dying from respiratory diseases.
Association between tobacco use and deaths from
cardiovascular diseases
Table 3 demonstrates the association between tobacco use
and deaths from cardiovascular diseases. From the Table 3,
there was no statistical significance for tobacco use and
Table 1 Percentage distribution of background






N=3,492 n (%) n (%)
Smoking status
Smokers 1,106 (31.7) 184 (16.6) 118 (10.7)
Non-smokers 2,386 (68.3) 193 (8.1) 253 (10.6)
Age group
15-29 560 (16.0) 33 (5.9) 19 (3.4)
30-49 1,604 (45.9) 160 (10.0) 137 (8.5)
50-59 1,328 (38.0) 184 (13.9) 215 (16.2)
Sex
Female 1,367 (39.2) 116 (8.5) 151 (11.1)
Male 2,125 (60.9) 261 (12.3) 220 (10.4)
Education
No education 1,584 (45.4) 175 (11.1) 194 (12.3)
Primary/JSS 1,336 (38.3) 150 (11.2) 108 (8.1)
Secondary/tertiary 391 (11.2) 30 (7.7) 51 (13.0)
Missing 180(5.2) 22 (12.2) 18 (10.0)
Place of residence
Rural 2,970 (85.1) 340 (11.5) 302 (10.2)
Urban 522 (15.90) 37 (7.1) 69 (13.2)
Socio-economic status
Poorest 751 (21.6) 85 (11.3) 77 (10.2)
Poorer 729 (21.0) 87 (11.9) 71 (9.7)
Poor 749 (21.6) 100 (13.4) 69 (9.2)
Less poor 763 (22.0) 70 (9.2) 83 (10.9)
Least poor 483 (13.9) 4 (7.0) 69 (14.3)
Frequency of smoking
Chain or hourly smoking 177 (5.1) 37 (20.9) 17 (9.6)
Daily smoking 858 (24.6) 138 (16.1) 90 (10.5)
Occasional smoking 71 (2.0) 9 (12.7) 11 (15.5)
No smoking 2,386 (68.3) 193 (8.1) 253 (10.6)
Duration of smoking
1-5 years 531 (15.2) 81 (15.3) 62 (11.7)
6-15 years 73 (2.1) 11 (15.1) 8 (11.0)
>15 years 502 (14.4) 92 (18.3) 48 (9.6)
Non-smokers 2,386 (68.3) 193 (8.1) 253 (10.6)
Total 3,492 377 (10.8) 371 (10.6)
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analysis, being older than 30 years and living in an urban
setting was associated with increased odds of dying from
cardiovascular diseases. For instance, the age group 50–59
years had over five-fold increased odds [OR = 5.51, 95%CI (3.1-9.2)] of dying from cardiovascular diseases
compared to the age group 15–29. In addition, urban
dwellers had more than one-fold increased odds [OR =
1.44, 95% CI (1.1-1.9)] of dying from cardiovascular
diseases compared to rural dwellers.
Relationship between length, frequency of smoking and
dying from respiratory diseases
Individuals who smoked were further classified into groups
based on the frequency of smoking and the duration of
smoking. Table 4 describes the relationship between fre-
quency of smoking and dying from respiratory diseases,
and between duration of smoking and dying from respira-
tory diseases. This has been examined in two separate re-
gression models. The odds of dying from respiratory
diseases increases based on the frequency of smoking. For
example, the multivariate analysis showed that chain/hourly
smokers had nearly three-fold increased odds [OR = 2.97,
95% CI (1.9-4.6)] of dying from respiratory diseases
compared to non-smokers. Those who smoked daily had
double the odds of dying from respiratory diseases com-
pared to non-smokers. Occasional smokers were also
more likely to die from respiratory diseases compared to
non-smokers, but this was not statistically significant.
In addition, the number of years of smoking was signifi-
cantly associated with dying from respiratory diseases.
The odds of dying from respiratory diseases increases with
increasing number of years an individual smoked. In
the multivariate analysis, for instance, individuals who
smoked for over 15 years had over two-fold increased
odds [OR = 2.32, 95% CI (1.6-3.2)] of dying from respira-
tory diseases compared to non-smokers.
Discussion
This study has illustrated that among the deaths re-
corded for the period in the study area, 31.7% smoked.
This is consistent with the results of a recent study con-
ducted in Ghana. Data from the World Health Organi-
zation’s (WHO) multi-country study on global aging and
adult health (SAGE) was analyzed and it revealed that
tobacco prevalence in the Upper East Region (the region
for our study), was 31.2% [19]. The finding might be
explained by the fact that rural areas usually have high
prevalence rates for tobacco use compared to semi-urban
and urban places [29,30]. For example, Chockalingam
et al. reported that tobacco use was significantly higher for
rural residence (23.7%) compared to semi-urban (20.9%)
and urban locations (19.4%) [31].
The study also demonstrated that smokers who died
from respiratory and cardiovascular diseases were 16.6%
and 10.7% respectively. This correlates with other studies
as well. Tobacco linked respiratory diseases were shown to
be responsible for about 22.1% of deaths in Canada for the
year 1998 [32]. In the case of cardiovascular diseases, Pérez
Table 2 Association between smoking and dying from respiratory diseases among deceased adults (n=3,492)
Variable Unadjusted P-value# *Adjusted P-value#
OR (95% CI) OR (95% CI)
Smoking status




30-49 1.8 (1.2-2.7) <0.001 1.35 (0.8-2.0) 0.002
50-59 2.63 (1.8-3.9) 1.99 (1.3-3.0)
Sex
Female 1 1
Male 1.51 (1.2-1.9) 0.006 0.98 (0.7-1.3) 0.904
Education
No education 1.49 (0.9-2.2)
Primary/JSS 1.52 (1.0-2.3) 0.117 NS NS
Secondary/tertiary 1
Place of residence
Rural 1.64 (1.1-2.3) 0.007 1.44 (0.9-2.2) 0.081
Urban 1 1
Socio-economic status
Poorest 1.61 (1.1-2.5) 1.31 (0.8-2.1)
Poorer 1.62 (1.1-2.5) 0.009 1.26 (0.8-2.0) 0.216
Poor 2.0 (1.3-3.0) 1.54 (0.9-2.4)
Less poor 1.29 (0.8-2.0) 1.08 (0.7-1.7)
Least poor (rich) 1 1
#Overall p-value.
NS – Not significant in bivariate analysis.
*Adjusted for age, sex, place of residence and wealth index in separate models.
Missing categories were not included in the regression models.
Dalinjong et al. Tobacco Induced Diseases  (2015) 13:12 Page 6 of 9et al. reported that deaths from cardiovascular diseases
among smokers in 1995 and 2007 respectively, were 52%
and 42% in Cuba [33]. However, the proportions reported
in their study are far higher than that reported in this
paper. According to the authors, their finding put Cuba in
the lead globally for deaths attributable to tobacco use.
Besides deaths from respiratory diseases were found to
be significantly related to smoking as reported in other
studies [15,34,35]. In the multivariate analysis, smoking
was still found to be a significant risk factor for deaths
due to respiratory diseases. This is supported by other
studies as well. In Bangladesh, for instance, tobacco use
was associated with 1.58 increased odds (99% CI 0.9-2.8)
of dying from respiratory diseases [36]. Our findings
showed that chained or frequent smokers (people who
smoked every hour) had higher chances of dying from re-
spiratory diseases, compared to non-smokers. The results
clearly showed a significant dose–response relationship
between dying from respiratory diseases and the quantity/amount of tobacco smoked [37,38]. A similar dose re-
sponse relationship was observed between the number of
years an individual smoked and deaths from respiratory
diseases. Thus, the study has demonstrated that tobacco
use is a major risk factor for deaths due to respiratory
diseases. Therefore tobacco control should be considered
a top priority in Ghana.
However, the study could not establish any significant
relationship between tobacco use and deaths from car-
diovascular diseases. Other studies exist to support our
finding. For instance, a prospective study conducted in
Bangladesh could not establish any clear association be-
tween smoking and deaths from overall cardiovascular
diseases [38]. Again, the Singapore Chinese Health Study
among men and women of Chinese ethnicity found no
apparent relationship between smoking and deaths from
stroke [39]. Contrary to our finding, other studies have
found a significant association between smoking and deaths
from cardiovascular diseases [11,40,41]. Further research
Table 3 Association between smoking and dying from cardiovascular diseases among deceased adults (n = 3,492)
Variable Unadjusted P-value# *Adjusted P-value#
OR (95% CI) OR (95% CI)
Smoking status
Smokers 1 1
Non-smokers 1.02 (0.8-1.3) 0.817 1.16 (0.9-1.5) 0.246
Age group
15-29 1 1
30-49 2.58 (1.6-4.3) <0.001 2.59 (1.7-4.9) <0.001
50-59 5.45 (3.3-8.9) 5.51 (3.1-9.2)
Sex
Female 1.11 (0.9-1.4) 0.357 NS NS
Male 1
Education
No education 1.58 (1.2-2.0) 1.21 (0.9-1.6)
Primary/JSS 1 0.004 1 0.080
Secondary/tertiary 1.70 (1.2-2.4) 1.49 (1.0-2.2)
Place of residence
Rural 1 1




Poor 1 0.151 NS NS
Less poor 1.22 (0.9-1.7)
Least poor (rich) 1.56 (1.1-2.3)
#Overall p-value.
NS – Not significant in bivariate analysis.
*Adjusted for age, sex, place of residence and wealth index in separate models.
Table 4 Relative odds of dying from respiratory diseases by frequency and duration of smoking
Variable Unadjusted P-value# Adjusted* P-value#
OR (95% CI) OR (95% CI)
Frequency of smoking
Chain/hourly smoking 3.19 (2.2-4.7) 2.97 (1.9-4.6)
Daily smoking 2.18 (1.7-2.8) <0.001 2.06 (1.5-2.8) <0.001
Occasional smoking 1.79 (0.9-3.7) 1.67 (0.8-3.5)
Non-smokers 1 1
Duration of smoking
1-5 years 2.13 (1.6-2.8) 2.13 (1.5-2.9)
6-15 years 2.12 (1.1-4.1) <0.001 1.87 (0.9-3.7) <0.001
>15 years 2.54 (1.9-3.4) 2.32 (1.6-3.2)
Non-smokers 1 1
#Overall p-value; *Adjusted for age, sex, place of residence and wealth index in separate models.
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INDEPTH Network sites which collects verbal autopsy
data.
Age especially is one of the most important factors de-
termining deaths from cardiovascular diseases. From this
study, older individuals as well as individuals living in
urban areas had increased odds of dying from cardiovas-
cular diseases. Similar findings exist elsewhere to support
our finding. Jiang et al. found that deaths resulting from
coronary heart disease in Tianjin (China) were higher
among older age groups and individuals living in urban
areas [42]. However, it is worrying to realize that people in
their prime ages or older are dying due to cardiovascular
diseases. The impact of these deaths are enormous on the
family, employer and the community due to the fact that
these people are either the bread winners for their fam-
ilies, the most experienced employees, or sometimes
leaders of their communities [43]. There is the need for
education on lifestyle habits (for example, dieting, alcohol
consumption, physical inactivity, etc.) especially for older
individuals as well as urban dwellers.
Study limitations
The use of the verbal autopsy tool for data collection
has its limitations including accuracy and recall bias by
the respondents. It is a challenge determining whether
the caregiver responding for the deceased is truthful in
his/her responses. Again, it is possible for non-smokers
to have died from tobacco related diseases (both respira-
tory and cardiovascular) due to exposure to second hand
smoke. Our study would not have captured such deaths
since the main exposure variable for the analysis was the
smoking status of the individual prior to his/her death.
Therefore our findings on the association between
smoking and deaths from both respiratory and cardio-
vascular diseases could have been underreported.
Nonetheless, the study was a population based study
with vigorous study oversight, well trained field staff for
data collection, and a well-defined health and demographic
surveillance system for monitoring deaths and other key
events. Again, the verbal autopsy tool for the study
was developed and standardized by the WHO and the
International Network for the Demographic Evaluation of
Populations and Their Health (INDEPTH Network).
Policy recommendations
In most sub-Saharan African countries including Ghana,
the challenges of tobacco use are emerging, but stringent
policies on smoking and use of tobacco products are
minimal and not effectively enforced. From the findings
of this study, it is clear that smoking is a significant pre-
dictor of deaths from respiratory diseases. This therefore,
calls for urgent need to re-assess the state of the implemen-
tation of the Framework Convention on Tobacco Control(FCTC) to reduce tobacco use among the adult population.
In Ghana particularly, the Public Health Bill incorporating
the Tobacco Control Bill requires quick action to become a
Legislative Instrument (LI) to allow for its enforceability.
The provisions of the Tobacco Control Bill if well enforced
will contribute to reducing respiratory and other tobacco
related diseases, thus minimizing premature deaths in the
country. Following our findings from this study, which took
place in a predominantly rural area, there is the need to en-
act policies addressing tobacco use in both rural and urban
areas.
Conclusions
The analysis showed an association between tobacco use and
deaths from respiratory diseases in the Kassena-Nankana
East and West districts. A significant relationship was
observed for tobacco use and deaths resulting from
respiratory diseases. Tobacco users were more prone to
dying from respiratory diseases compared to non-users.
Our study could not establish any significant relationship
between tobacco use and deaths from cardiovascular
diseases. Only age and urban location were found to be
strong predictors of deaths from cardiovascular diseases.
There is need to adopt appropriate health interventions to
control tobacco use. Controlling tobacco use can contrib-
ute to reducing respiratory and other tobacco linked
diseases and by extension deaths related to tobacco usage.
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